Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Fluent Ventures is a global venture capital firm founded to invest in early-stage companies. Established with the backing of over 75 unicorn founders, technology experts, venture capitalists, and institutional investors, the firm focuses on investments ranging from pre-seed to Series A stages. Fluent Ventures operates with a global perspective, targeting regions including North America, Europe, Africa, Latin America, and the Middle East & North Africa.
The firm has built a notable portfolio of 12 companies, emphasizing its commitment to diverse sectors such as fintech, commerce, and healthcare. Fluent Ventures aims to partner with local funds to enhance its investment strategy and leverage regional expertise.
Fluent Ventures invests primarily in three sectors: fintech, commerce, and healthcare. In fintech, the firm focuses on transforming financial services, including payments, savings, lending, and insurance. The commerce sector involves changing how businesses source, buy, sell, and create ecosystems. In healthcare, Fluent Ventures aims to improve access and outcomes through technology while explicitly avoiding investments in biotech.
The firm typically invests between $250,000 and $2 million, targeting early-stage companies at the pre-seed to Series A levels. Fluent Ventures prefers to collaborate with local funds, which allows them to tap into regional insights and enhance their investment strategies.
Fluent Ventures has a diverse portfolio of 12 companies, showcasing its investment strategy across various sectors:
Alex Lazarow – Managing Partner. Alex has extensive experience in venture capital and has led multiple successful investments in early-stage companies.
JC Glancy – Venture Partner. JC brings a wealth of knowledge in technology and finance, having worked with various startups and established firms.
Lucas Ward – Venture Partner. Lucas has a strong background in fintech and has been instrumental in guiding portfolio companies in that sector.
Clay Kellogg – Venture Partner. Clay specializes in commerce and has a track record of successful investments in e-commerce platforms.
Sofia A. Illsley Rangel – Investor. Sofia focuses on healthcare investments and has a keen interest in improving access to healthcare through technology.
Rakesh Apte – Venture Partner. Rakesh has a diverse background in venture capital and has led investments across various sectors.
Founders should submit their pitches through the Fluent Ventures contact page. It is advisable to include a concise deck that outlines the business model, market opportunity, and team background. Response times may vary, but founders can expect to hear back within a few weeks.
What are Fluent Ventures' investment criteria?
Fluent Ventures invests in early-stage companies at the pre-seed to Series A stages, focusing on fintech, commerce, and healthcare sectors. They typically invest between $250,000 and $2 million.
How can I pitch to Fluent Ventures?
Founders can pitch their startups by visiting the Fluent Ventures contact page at Fluent Ventures Contact Page. It is recommended to provide a clear overview of the business model, market opportunity, and team.
What makes Fluent Ventures different from other investors?
Fluent Ventures distinguishes itself by its global investment approach and its backing from over 75 unicorn founders and technology experts. This extensive network enhances collaboration and investment opportunities.
What is Fluent Ventures' geographic focus?
The firm has a global investment focus, including North America, Europe, Africa, Latin America, and the Middle East & North Africa.
What is Fluent Ventures' involvement post-investment?
Fluent Ventures actively supports its portfolio companies through mentorship, operational support, and access to its extensive network of founders and industry experts.
What sectors does Fluent Ventures avoid?
Fluent Ventures explicitly avoids investments in biotech, focusing instead on fintech, commerce, and healthcare.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.